Do You Have a Child Under the Age of 17 Months?
The ORBEX Study is a three year study that aims to see if a medication can help prevent wheezing in young children.
We are inviting children under the age of 17 months who meet one or more of the following requirements to participate:
- The child has eczema
- One of the child’s parents has or had asthma
- The child has a sibling aged 4 years or older with asthma
After the first visit, there will be a trial period to see how well you follow a practice medication schedule for your child. If you are able to give your child the capsules most of the time, your child will be randomly assigned to take either the study medication or a placebo capsule. You will not know which one your child is taking.
There will be 12 planned study visits and 26 planned study phone calls throughout the three years.
Participants will be reimbursed for each completed study visit and monthly phone call.
For more information, please contact: Download flyer
Betsy Cowin, MSW
About Children's National Health System:
Children’s National Health System, based in Washington, DC, has been serving the nation’s children since 1870. Children’s National is ranked #1 for babies and top 10 overall by U.S. News & World Report. Also a designated a Leapfrog Group Top Hospital and a two-time recipient of Magnet® status, this pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is one of the nation’s top NIH-funded pediatric institutions. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. For more information, visit ChildrensNational.org, or follow us on Facebook and Twitter.